Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2025 08:00 ET | Source: Pet Innovation Awards

CHARM® PET FOOD Receives “Health Focused Product of the Year” In 2025 Pet Innovation Awards

LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that CHARM® PET FOOD has been selected as the winner of “Health Focused Product of the Year.” The Pet...
August 13, 2025 11:00 ET | Source: Pet Innovation Awards

Pet's Best Life Wins “Overall Dog Health Product of the Year” For Longevity15® In 2025 Pet Innovation Awards

LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that Longevity15® from Pet's Best Life has been selected as “Overall Dog Health Product of the Year.”...
August 12, 2025 07:00 ET | Source: NodThera

NodThera Demonstrates Reversal of Neuroinflammation and Inflammation in Parkinson’s Disease with Oral NLRP3 Inhibitor

NodThera Demonstrates Reversal of Neuroinflammation and Inflammation in Parkinson’s Disease with Oral NLRP3 Inhibitor Phase 1b/2a study results published in Movement Disorders journalOral,...
August 12, 2025 04:04 ET | Source: Research and Markets

Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Vitiligo Treatment...
August 01, 2025 04:30 ET | Source: Research and Markets

Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases

Dublin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The "Tenosynovitis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
July 21, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership TeamWill spearhead clinical...
July 15, 2025 09:00 ET | Source: Evestia Clinical

Evestia Clinical to merge with Atlantic Research Group

Evestia Clinical to merge with Atlantic Research Group
June 24, 2025 05:32 ET | Source: Research and Markets

Vasculitis Market Analysis Report 2025-2035, Competitive Analysis of GlaxoSmithKline, Mitsubishi Tanabe Pharma, Novartis, and Amgen

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Vasculitis Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's...
June 17, 2025 13:42 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. ...
June 17, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Elisabeth Björk as Board Member

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in obesity and cardiometabolic research, portfolio strategy development and...